DK169972B1 - Fremgangsmåde til fremstilling af præparater indeholdende vincristin- og vinblastin-metalion-complexer, samt sådanne præparater - Google Patents

Fremgangsmåde til fremstilling af præparater indeholdende vincristin- og vinblastin-metalion-complexer, samt sådanne præparater Download PDF

Info

Publication number
DK169972B1
DK169972B1 DK472085A DK472085A DK169972B1 DK 169972 B1 DK169972 B1 DK 169972B1 DK 472085 A DK472085 A DK 472085A DK 472085 A DK472085 A DK 472085A DK 169972 B1 DK169972 B1 DK 169972B1
Authority
DK
Denmark
Prior art keywords
zinc
calcium
vinblastine
magnesium
vineristin
Prior art date
Application number
DK472085A
Other languages
Danish (da)
English (en)
Other versions
DK472085D0 (da
DK472085A (da
Inventor
Geza Takacsi Nagy
Gabor Szepesi
Maria Gazdag
Zsofia Pap
Kalman Burger
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of DK472085D0 publication Critical patent/DK472085D0/da
Publication of DK472085A publication Critical patent/DK472085A/da
Application granted granted Critical
Publication of DK169972B1 publication Critical patent/DK169972B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
DK472085A 1984-10-16 1985-10-15 Fremgangsmåde til fremstilling af præparater indeholdende vincristin- og vinblastin-metalion-complexer, samt sådanne præparater DK169972B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU843861A HU195513B (en) 1984-10-16 1984-10-16 Process for producing stable solutions of alkaloides with bis-indole skeleton
HU386184 1984-10-16

Publications (3)

Publication Number Publication Date
DK472085D0 DK472085D0 (da) 1985-10-15
DK472085A DK472085A (da) 1986-04-17
DK169972B1 true DK169972B1 (da) 1995-04-18

Family

ID=10965811

Family Applications (1)

Application Number Title Priority Date Filing Date
DK472085A DK169972B1 (da) 1984-10-16 1985-10-15 Fremgangsmåde til fremstilling af præparater indeholdende vincristin- og vinblastin-metalion-complexer, samt sådanne præparater

Country Status (29)

Country Link
US (1) US4684638A (lv)
JP (1) JPS61106584A (lv)
CN (1) CN1007958B (lv)
AT (1) AT389996B (lv)
AU (1) AU580342B2 (lv)
BE (1) BE903447A (lv)
CA (1) CA1272192A (lv)
CH (1) CH667459A5 (lv)
CS (1) CS251798B2 (lv)
DD (1) DD239207A5 (lv)
DE (1) DE3536745A1 (lv)
DK (1) DK169972B1 (lv)
ES (1) ES8701185A1 (lv)
FI (1) FI84134C (lv)
FR (1) FR2571724B1 (lv)
GB (1) GB2165540B (lv)
GR (1) GR852510B (lv)
HU (1) HU195513B (lv)
IE (1) IE58467B1 (lv)
IL (1) IL76719A (lv)
IN (1) IN162910B (lv)
IT (1) IT1186776B (lv)
LT (1) LT2203B (lv)
LU (1) LU86115A1 (lv)
LV (1) LV5175A3 (lv)
NL (1) NL192779C (lv)
SE (1) SE466017B (lv)
SU (1) SU1706372A3 (lv)
ZA (1) ZA857905B (lv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341262C (en) * 1987-08-06 2001-06-26 Camille A. Boulet A new process of the synthesis of 3',4'-anhydrovinblastine, vinblastine and vincristine
US5170515A (en) * 1987-09-16 1992-12-15 Toto Ltd. Water closet
FR2623089B1 (fr) * 1987-11-13 1990-04-27 Pf Medicament Composition pharmaceutique pour l'administration parenterale de navelbine
HU204995B (en) * 1989-11-07 1992-03-30 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US8017368B2 (en) * 2005-10-20 2011-09-13 University Of South Florida Molecular delivery to cells using aspirin-related compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE595570C (de) * 1932-10-07 1934-04-16 I G Farbenindustrie Akt Ges Verfahren zur Darstellung waesseriger Loesungen von Schwermetallverbindungen der aromatischen Halogenylsulfamide
US3426024A (en) * 1967-11-17 1969-02-04 Vanderbilt Co R T Amine complexes of zinc salts of chlorinated thiobisphenols
DE2502932C2 (de) * 1975-01-24 1985-04-18 Bayer Ag, 5090 Leverkusen Metallkomplexe von N-Trityl-azolen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Fungizide
FR2349335A1 (fr) * 1976-04-28 1977-11-25 Inst Int Pathologie Cellulaire Complexes d'alcaloides bis-indoliques du type vinblastine avec la tubuline, leur procede d'obtention et leur utilisation
DE2967049D1 (en) * 1978-04-11 1984-07-19 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
ATE11014T1 (de) * 1981-07-14 1985-01-15 Efamol Limited Pharmazeutische und diaetetische zusammensetzung zur erhoehung der serie-l-pg-produktion.
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi

Also Published As

Publication number Publication date
ES547862A0 (es) 1986-11-16
AU580342B2 (en) 1989-01-12
LU86115A1 (de) 1986-03-24
DE3536745A1 (de) 1986-04-17
US4684638A (en) 1987-08-04
CA1272192A (en) 1990-07-31
FI84134B (fi) 1991-07-15
CH667459A5 (de) 1988-10-14
FR2571724B1 (fr) 1988-08-26
IN162910B (lv) 1988-07-23
DK472085D0 (da) 1985-10-15
NL192779C (nl) 1998-02-03
BE903447A (fr) 1986-04-15
LV5175A3 (lv) 1993-10-10
ATA297985A (de) 1989-08-15
GB8525360D0 (en) 1985-11-20
ZA857905B (en) 1986-06-25
SU1706372A3 (ru) 1992-01-15
CN85107053A (zh) 1986-06-10
GB2165540A (en) 1986-04-16
NL192779B (nl) 1997-10-01
FR2571724A1 (fr) 1986-04-18
JPS61106584A (ja) 1986-05-24
IT1186776B (it) 1987-12-16
SE8504786L (sv) 1986-04-17
AU4871485A (en) 1986-04-24
ES8701185A1 (es) 1986-11-16
CN1007958B (zh) 1990-05-16
NL8502821A (nl) 1986-05-16
FI853123L (fi) 1986-04-17
GB2165540B (en) 1988-04-27
IL76719A (en) 1989-10-31
HU195513B (en) 1988-05-30
LT2203B (lt) 1993-10-15
IT8522482A0 (it) 1985-10-15
SE8504786D0 (sv) 1985-10-15
GR852510B (lv) 1986-02-18
IE58467B1 (en) 1993-09-22
FI84134C (fi) 1991-10-25
CS251798B2 (en) 1987-08-13
IE852531L (en) 1986-04-16
DD239207A5 (de) 1986-09-17
DK472085A (da) 1986-04-17
FI853123A0 (fi) 1985-08-15
DE3536745C2 (lv) 1992-01-23
IL76719A0 (en) 1986-02-28
AT389996B (de) 1990-02-26
JPH0339489B2 (lv) 1991-06-14
SE466017B (sv) 1991-12-02

Similar Documents

Publication Publication Date Title
AP957A (en) Novel stable liquid paracetamol compositions, and method for preparing same.
JP4929352B2 (ja) 注入可能なパラセタモール液剤
NO336427B1 (no) Farmasøytisk sammensetning av vinflunin som er ment for parenteral administrering, fremstillingsmåte og anvendelse derav
CA2128641A1 (en) Stabilized solutions of platinum (ii) antitumor agents
DK169972B1 (da) Fremgangsmåde til fremstilling af præparater indeholdende vincristin- og vinblastin-metalion-complexer, samt sådanne præparater
EP3181120A1 (en) Enema composition for treatment of ulcerative colitis having long term stability
HU177557B (en) Process for preparing stable aequous sterile solution of cys-platinic/ii/-diamine-dichloride
EP4422692A1 (en) Phytonadione for parenteral administration
US4915956A (en) Liquid cisplatin formulations
CA2585866A1 (en) Stable aqueous formulation of a platin derivative
RU2188640C1 (ru) Фармацевтическая композиция с противоопухолевой активностью на основе карбоплатина
HU181940B (en) Process for producing solutions of vincane derivatives for parentheral application
KR20220088562A (ko) 안정성이 개선된 타우로리딘 액상제형 의약 조성물 및 이의 제조방법
WO2023119188A1 (en) Composition of compound comprising 3-hydroxycyclopentanone moiety and method of its stabilization
CZ300664B6 (cs) Sterilní kapalná farmaceutická kompozice a zpusob její výroby
WO2019176239A1 (ja) 容器充填ヒトｐｔｈ（１－３４）液体医薬組成物及びその製造方法
CN116251057A (zh) 一种硝酸异山梨酯注射液及其制备方法
CZ300665B6 (cs) Sterilní kapalná farmaceutická kompozice a zpusob její výroby

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK